Travere Therapeutics (TVTX) Operating Margin Growth (1y) (2015 - 2026)
Travere Therapeutics (TVTX) Operating Margin Growth (1y) (2015 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1,049.00 |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1,238.00 |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | -10,520.00 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | -1,651.00 |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 2,002.00 |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 29,091.00 |
| 10 | Travere Therapeutics | 5.85 Bn | 5.85 Bn | 162.52 Mn | 1,338.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1,338.00 |
| Mar 31, 2026 | 2,319.00 |
| Dec 31, 2025 | 9,043.00 |
| Sep 30, 2025 | 15,160.00 |
| Jun 30, 2025 | 11,406.00 |
| Mar 31, 2025 | 28,432.00 |
| Dec 31, 2024 | 12,792.00 |
| Sep 30, 2024 | 16,032.00 |
| Jun 30, 2024 | 19,776.00 |
| Mar 31, 2024 | -2,130.00 |
| Dec 31, 2023 | 8,639.00 |
| Sep 30, 2023 | 4,464.00 |
| Jun 30, 2023 | -4,863.00 |
| Mar 31, 2023 | -778.00 |
| Dec 31, 2022 | -34,914.00 |
| Sep 30, 2022 | -24,774.00 |
| Jun 30, 2022 | -20,958.00 |
| Mar 31, 2022 | -20,715.00 |
| Dec 31, 2021 | 28,615.00 |
| Sep 30, 2021 | -848.00 |